| Literature DB >> 29599407 |
S Fjalldal1, C Follin1, D Svärd2, L Rylander3, S Gabery4, Å Petersén4, D van Westen2, P C Sundgren2,5, I M Björkman-Burtscher2,5, J Lätt5, B Ekman6, A Johanson7, E M Erfurth8.
Abstract
CONTEXT: Patients with craniopharyngioma (CP) and hypothalamic lesions (HL) have cognitive deficits. Which neural pathways are affected is unknown.Entities:
Mesh:
Year: 2018 PMID: 29599407 PMCID: PMC5937918 DOI: 10.1530/EJE-18-0081
Source DB: PubMed Journal: Eur J Endocrinol ISSN: 0804-4643 Impact factor: 6.664
Patients’ baseline characteristics and tumor treatment modalities shown separate for patients with hypothalamic (HT) lesion and without.*,≠
| Gender | Age at investigation (y) | Age at first operation (y) | Treatment | Hormone substitution |
|---|---|---|---|---|
| With HT lesion ( | ||||
| F | 38 | 20 | S | G/Ta |
| F | 46 | 27 | S | GHc |
| F | 36 | 12 | S | GH/G/T/C/ADHc |
| F | 56 | 7 | S+CRT∞ | GH/G/T/C |
| F | 33 | 3 | S+CRT+In | GH/G/T/C/ADH |
| F | 33 | 5 | S+CRT | GH/G/T/C/ADH |
| F | 32 | 15 | S+CRT | GH/G/T/C/ADH |
| F | 29 | 13 | S | GH/G/T/C/ADH |
| F | 28 | 4 | S+CRT | GH/G/T/C/ADH |
| F | 40 | 22 | S+In | GH/G/T/C/ADH |
| F | 35 | 29 | S | GH/G/T/C/ADH |
| F | 19 | 7 | S | GH/G/T/C/ADH |
| F | 37 | 9 | S+CRT | GH/G/T/C/ADH |
| M | 43 | 9 | S+CRT+In | GH/G/T/C/ADHc |
| M | 20 | 9 | S+CRT | Noneb |
| M | 33 | 22 | S+CRT | GH/G/T/C |
| M | 49 | 12 | S | GH/G/T/C/ADH |
| M | 35 | 6 | S+CRT+In+SR | GH/G/T/C/ADH |
| M | 21 | 9 | S | GH/G/T/C/ADH |
| M | 38 | 16 | S+CRT | GH/G/T/C/ADH |
| M | 37 | 8 | S+CRT | GH/G/T/C/ADH |
| M | 35 | 16 | S+CRT | GH/G/T/C/ADH |
| Without HT lesion ( | ||||
| F | 49 | 12 | S | ADHa |
| F | 47 | 12 | S | T/ADHa |
| F | 25 | 21 | S | T/ADHb |
| F | 41 | 11 | S | Noneb |
| F | 34 | 15 | S | GH/G/ADH |
| F | 40 | 11 | S | GH/G/T/C/ADH |
| F | 38 | 9 | S | GH/G/T/C/ADH |
| F | 32 | 10 | S | GH/G/T/C/ADH |
| F | 29 | 17 | S | GH/G/T/C/ADH |
| F | 18 | 6 | S+In+SR | GH/G/T/C/ADH |
| F | 30 | 5 | S+CRT | GH/G/T/C/ADH |
| M | 40 | 17 | S | ADHa |
| M | 35 | 14 | S | GH/G/T/ADH |
| M | 47 | 5 | S | GH/G/T/C/ADH |
| M | 46 | 14 | S | GH/G/T/C/ADH |
| M | 37 | 3 | S | GH/G/T/C/ADH |
| M | 36 | 14 | S | GH/G/T/C/ADH |
| M | 27 | 4 | S+CRT | GH/G/T/C/ADH |
*Hypothalamic lesion according to the neurosurgeon’s retrospective assignment of patients to the non-hypothalamic lesion and hypothalamic lesion group based on operation records. ≠27 patients had 1 operation (13 hypothalamic lesion), 11 patients had 2 operations (8 hypothalamic lesion), 3 patients had 3 operations (2 hypothalamic lesion). ∞35 Gy Cobalt three-field’s technique. aIntact GH axis based on insulin tolerance test. bIntact GH axis based on clinical judgment. cGH deficient but stopped GH treatment.
ADH, antidiuretic hormone; C, cortisone; CRT, cranial radiotherapy; F, female; G, gonadal steroids; GH, growth hormone; In, installation of yttrium; M, male; S, surgery; SR, stereotactic radiosurgery; T, levothyroxine; y, years.
Neuropsychological test scores of 23* childhood-onset CP patients with Hypothalamic (HT) lesion and 32 controls.
| Patients with HT lesion ( | Controls ( | ||||
|---|---|---|---|---|---|
| Median | 10th–90th percentiles | Median | 10th–90th percentiles | ||
| Semantic memory (WAIS vocabulary) | 31 | 18–40 | 38 | 30–47 | |
| Episodic memory | |||||
| Verbal memory (RAVLT) | |||||
| Immediate recall | 51 | 31–65 | 57 | 44–68 | 0.054 |
| Delayed recall | 11 | 2–15 | 12 | 7–15 | |
| Recognition | 13 | 10–15 | 15 | 12–15 | |
| Visual memory (Rey Complex Figure) | |||||
| Immediate recall | 17 | 6–29 | 23 | 15–28 | 0.061 |
| Delayed recall | 17 | 6–27 | 23 | 13–28 | |
| Recognition | 21 | 20–23 | 22 | 19–23 | ns |
| Working memory (WAIS digit span) | 27 | 19–33 | 27 | 19–37 | ns |
| Executive function, processing speed | |||||
| WAIS digit span – backward subtest | 9 | 5–12 | 9 | 6–13 | ns |
| WAIS coding | 71 | 50–88 | 75 | 59–101 | ns |
| Trail making test | |||||
| Test 1 | 22 | 17–39 | 19 | 14–27 | |
| Test 2 | 25 | 19–39 | 22 | 16–32 | ns |
| Test 3 | 28 | 22–41 | 23 | 15–37 | |
| Test 4 | 65 | 46–105 | 60 | 38–98 | ns |
| Test 5 | 32 | 17–50 | 22 | 14–32 | |
| Visuospatial abilities | |||||
| Rey complex figure copy | 35 | 32–36 | 35 | 32–36 | ns |
| WAIS block design | 52 | 30–60 | 52 | 31–60 | ns |
*n = 23 with following exceptions: WAIS block design n = 22 as one patient was excluded due to visual problems, WAIS coding n = 16 as 7 patients were excluded due to visual problems, Trail making test n = 16 as 7 patients were excluded due to visual problems, Rey Complex Figure Test n = 16 as 7 patients were excluded due to visual problems.
Figure 1Graphical renderings of directionally color-coded (red, right-left; green, anterior-posterior; blue, superior-inferior) segmented tractography of (A) dorsal cingulum, (B) ventral cingulum, (C) fornix, and (D) uncinate fasciculus superimposed on a mid-sagittal FA map in a representative subject.
Figure 2An example of a typical MPRAGE image in the three orthogonal planes, with Hippocampus region outlined in white, obtained from FreeSurfer (http://surfer.nmr.mgh.harvard.edu/).
Figure 3Episodic visual memory (Rey Complex Figure Test) with Immediate recall (A) and Delayed recall (B) in association to DTI in the left ventral cingulum (MD; mean diffusivity) among 32 CP patients. (C) Cognitive test of general knowledge in relation to DTI (FA; fractional anisotropy in the right uncinate fasciculus). Pearson’s correlation coefficient (r). (D) Cognitive test of General knowledge in relation to total hippocampal volume among 34 CP patients. Pearson’s correlation coefficient (r).